» Articles » PMID: 30428559

The Combined Effects of Co-Culture and Substrate Mechanics on 3D Tumor Spheroid Formation Within Microgels Prepared Via Flow-Focusing Microfluidic Fabrication

Overview
Journal Pharmaceutics
Publisher MDPI
Date 2018 Nov 16
PMID 30428559
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Tumor spheroids are considered a valuable three dimensional (3D) tissue model to study various aspects of tumor physiology for biomedical applications such as tissue engineering and drug screening as well as basic scientific endeavors, as several cell types can efficiently form spheroids by themselves in both suspension and adherent cell cultures. However, it is more desirable to utilize a 3D scaffold with tunable properties to create more physiologically relevant tumor spheroids as well as optimize their formation. In this study, bioactive spherical microgels supporting 3D cell culture are fabricated by a flow-focusing microfluidic device. Uniform-sized aqueous droplets of gel precursor solution dispersed with cells generated by the microfluidic device are photocrosslinked to fabricate cell-laden microgels. Their mechanical properties are controlled by the concentration of gel-forming polymer. Using breast adenocarcinoma cells, MCF-7, the effect of mechanical properties of microgels on their proliferation and the eventual spheroid formation was explored. Furthermore, the tumor cells are co-cultured with macrophages of fibroblasts, which are known to play a prominent role in tumor physiology, within the microgels to explore their role in spheroid formation. Taken together, the results from this study provide the design strategy for creating tumor spheroids utilizing mechanically-tunable microgels as 3D cell culture platform.

Citing Articles

Polydopamine Interfacial Coating for Stable Tumor-on-a-Chip Models: Application for Pancreatic Ductal Adenocarcinoma.

Hernandez-Hatibi S, Guerrero P, Garcia-Aznar J, Garcia-Gareta E Biomacromolecules. 2024; 25(8):5169-5180.

PMID: 39083627 PMC: 11323005. DOI: 10.1021/acs.biomac.4c00551.


Uniform sized cancer spheroids production using hydrogel-based droplet microfluidics: a review.

Kim S, Lam P, Jayaraman A, Han A Biomed Microdevices. 2024; 26(2):26.

PMID: 38806765 PMC: 11241584. DOI: 10.1007/s10544-024-00712-3.


Microfluidics and Organoids, the Power Couple of Developmental Biology and Oncology Studies.

Hetzel L, Ali A, Corbo V, Hankemeier T Int J Mol Sci. 2023; 24(13).

PMID: 37446057 PMC: 10341942. DOI: 10.3390/ijms241310882.


Collagen-Tannic Acid Spheroids for β-Cell Encapsulation Fabricated Using a 3D Bioprinter.

Clua-Ferre L, De Chiara F, Rodriguez-Comas J, Comelles J, Martinez E, Godeau A Adv Mater Technol. 2023; 7(7):2101696.

PMID: 37182094 PMC: 10170414. DOI: 10.1002/admt.202101696.


Spheroid Engineering in Microfluidic Devices.

Tevlek A, Kecili S, Ozcelik O, Kulah H, Tekin H ACS Omega. 2023; 8(4):3630-3649.

PMID: 36743071 PMC: 9893254. DOI: 10.1021/acsomega.2c06052.


References
1.
Santini M, Rainaldi G, Indovina P . Apoptosis, cell adhesion and the extracellular matrix in the three-dimensional growth of multicellular tumor spheroids. Crit Rev Oncol Hematol. 2000; 36(2-3):75-87. DOI: 10.1016/s1040-8428(00)00078-0. View

2.
Bilati U, Allemann E, Doelker E . Sonication parameters for the preparation of biodegradable nanocapsules of controlled size by the double emulsion method. Pharm Dev Technol. 2003; 8(1):1-9. DOI: 10.1081/pdt-120017517. View

3.
Kelm J, Timmins N, Brown C, Fussenegger M, Nielsen L . Method for generation of homogeneous multicellular tumor spheroids applicable to a wide variety of cell types. Biotechnol Bioeng. 2003; 83(2):173-80. DOI: 10.1002/bit.10655. View

4.
Shu X, Liu Y, Palumbo F, Prestwich G . Disulfide-crosslinked hyaluronan-gelatin hydrogel films: a covalent mimic of the extracellular matrix for in vitro cell growth. Biomaterials. 2003; 24(21):3825-34. DOI: 10.1016/s0142-9612(03)00267-9. View

5.
Palamakula A, Khan M . Evaluation of cytotoxicity of oils used in coenzyme Q10 Self-emulsifying Drug Delivery Systems (SEDDS). Int J Pharm. 2004; 273(1-2):63-73. DOI: 10.1016/j.ijpharm.2003.12.010. View